LAMEA Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of Administration (Injectable and Oral & Others), By Application, By Drug Class, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Gastrointestinal Therapeutics Market would witness market growth of 9.6% CAGR during the forecast period (2022-2028).

Structural gastrointestinal disease is when one’s bowel looks abnormal during the examination and doesn’t function properly. In some cases, the structural abnormality is required to be removed surgically. Structural GI diseases include strictures, hemorrhoids, inflammatory bowel disease, colon cancer, colon polyps, and stenosis.

Constipation, a functional problem, makes it hard for the patient to have a bowel movement (or pass stools). As a result, the stools are infrequent (less than three times a week) or incomplete. Constipation is generally caused by an inadequate “roughage” or fiber in one’s diet or disruption in their routine. Constipation usually doesn’t mean any serious medical condition.

Irritable bowel syndrome (also called spastic colon, IBS, nervous stomach or irritable colon) is a functional condition where the patients colon muscle contracts more or less often than “normal”. Certain foods, medicines and emotional stress are some factors which are known to triggers IBS. Hemorrhoids are expanded veins in the anal canal, which cause a structural disease.

Dubai spent around AED 19.49 billion on healthcare which was 5.3 % of their GDP, the annual growth rate was just 1% after accounting for change in the utilization pattern because of the COVID-19 pandemic. The spending on ancillary services and medical goods was 13% and 15% respectively. The spending on perspective care services were lower than 1% and the government allocated 23% of their health expenditure to administration and governance functions. The private insurance spent 36% of their total health expenditure on ancillary services and medical goods.

The Brazil market dominated the LAMEA Gastrointestinal Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,032.1 million by 2028. The Argentina market is estimated to grow a CAGR of 10.2% during (2022 - 2028). Additionally, The UAE market would experience a CAGR of 9.3% during (2022 - 2028).

Based on Type, the market is segmented into Branded and Generics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Route of Administration, the market is segmented into Injectable and Oral & Others. Based on Application, the market is segmented into Crohn's Disease, Ulcerative Colitis, GERD, IBS and Others. Based on Drug Class, the market is segmented into Biologics/Biosimilar, Anti-Diarrheal, Anti-Emetics, Digestive Enzymes, Aminosalicylates, Proton Pump Inhibitors, Laxatives & H2 Antagonists and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Gastrointestinal Therapeutics Market is Predict to reach $45.9 Billion by 2028, at a CAGR of 3.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, AbbVie, Inc., Takeda Pharmaceutical Company Limited, Pfizer, Inc., Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.), Johnson & Johnson (Janssen Global Services, LLC), AstraZeneca PLC, Bayer AG, Sun Pharmaceutical Industries Ltd., and Cipla Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Branded
• Generics

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Route of Administration

• Injectable
• Oral & Others

By Application

• Crohn's Disease
• Ulcerative Colitis
• GERD
• IBS
• Others

By Drug Class

• Biologics/Biosimilar
• Anti-Diarrheal
• Anti-Emetics
• Digestive Enzymes
• Aminosalicylates
• Proton Pump Inhibitors
• Laxatives & H2 Antagonists
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• AbbVie, Inc.
• Takeda Pharmaceutical Company Limited
• Pfizer, Inc.
• Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
• Johnson & Johnson (Janssen Global Services, LLC)
• AstraZeneca PLC
• Bayer AG
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Gastrointestinal Therapeutics Market, by Type
1.4.2 LAMEA Gastrointestinal Therapeutics Market, by Distribution Channel
1.4.3 LAMEA Gastrointestinal Therapeutics Market, by Route of Administration
1.4.4 LAMEA Gastrointestinal Therapeutics Market, by Application
1.4.5 LAMEA Gastrointestinal Therapeutics Market, by Drug Class
1.4.6 LAMEA Gastrointestinal Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Gastrointestinal Therapeutics Market

Chapter 4. LAMEA Gastrointestinal Therapeutics Market by Type
4.1 LAMEA Branded Market by Country
4.2 LAMEA Generics Market by Country

Chapter 5. LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
5.1 LAMEA Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Gastrointestinal Therapeutics Market by Route of Administration
6.1 LAMEA Injectable Market by Country
6.2 LAMEA Oral & Others Market by Country

Chapter 7. LAMEA Gastrointestinal Therapeutics Market by Application
7.1 LAMEA Crohn's Disease Market by Country
7.2 LAMEA Ulcerative Colitis Market by Country
7.3 LAMEA GERD Market by Country
7.4 LAMEA IBS Market by Country
7.5 LAMEA Others Market by Country

Chapter 8. LAMEA Gastrointestinal Therapeutics Market by Drug Class
8.1 LAMEA Biologics/Biosimilar Market by Country
8.2 LAMEA Anti-Diarrheal Market by Country
8.3 LAMEA Anti-Emetics Market by Country
8.4 LAMEA Digestive Enzymes Market by Country
8.5 LAMEA Aminosalicylates Market by Country
8.6 LAMEA Proton Pump Inhibitors Market by Country
8.7 LAMEA Laxatives & H2 Antagonists Market by Country
8.8 LAMEA Others Market by Country

Chapter 9. LAMEA Gastrointestinal Therapeutics Market by Country
9.1 Brazil Gastrointestinal Therapeutics Market
9.1.1 Brazil Gastrointestinal Therapeutics Market by Type
9.1.2 Brazil Gastrointestinal Therapeutics Market by Distribution Channel
9.1.3 Brazil Gastrointestinal Therapeutics Market by Route of Administration
9.1.4 Brazil Gastrointestinal Therapeutics Market by Application
9.1.5 Brazil Gastrointestinal Therapeutics Market by Drug Class
9.2 Argentina Gastrointestinal Therapeutics Market
9.2.1 Argentina Gastrointestinal Therapeutics Market by Type
9.2.2 Argentina Gastrointestinal Therapeutics Market by Distribution Channel
9.2.3 Argentina Gastrointestinal Therapeutics Market by Route of Administration
9.2.4 Argentina Gastrointestinal Therapeutics Market by Application
9.2.5 Argentina Gastrointestinal Therapeutics Market by Drug Class
9.3 UAE Gastrointestinal Therapeutics Market
9.3.1 UAE Gastrointestinal Therapeutics Market by Type
9.3.2 UAE Gastrointestinal Therapeutics Market by Distribution Channel
9.3.3 UAE Gastrointestinal Therapeutics Market by Route of Administration
9.3.4 UAE Gastrointestinal Therapeutics Market by Application
9.3.5 UAE Gastrointestinal Therapeutics Market by Drug Class
9.4 Saudi Arabia Gastrointestinal Therapeutics Market
9.4.1 Saudi Arabia Gastrointestinal Therapeutics Market by Type
9.4.2 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel
9.4.3 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration
9.4.4 Saudi Arabia Gastrointestinal Therapeutics Market by Application
9.4.5 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class
9.5 South Africa Gastrointestinal Therapeutics Market
9.5.1 South Africa Gastrointestinal Therapeutics Market by Type
9.5.2 South Africa Gastrointestinal Therapeutics Market by Distribution Channel
9.5.3 South Africa Gastrointestinal Therapeutics Market by Route of Administration
9.5.4 South Africa Gastrointestinal Therapeutics Market by Application
9.5.5 South Africa Gastrointestinal Therapeutics Market by Drug Class
9.6 Nigeria Gastrointestinal Therapeutics Market
9.6.1 Nigeria Gastrointestinal Therapeutics Market by Type
9.6.2 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel
9.6.3 Nigeria Gastrointestinal Therapeutics Market by Route of Administration
9.6.4 Nigeria Gastrointestinal Therapeutics Market by Application
9.6.5 Nigeria Gastrointestinal Therapeutics Market by Drug Class
9.7 Rest of LAMEA Gastrointestinal Therapeutics Market
9.7.1 Rest of LAMEA Gastrointestinal Therapeutics Market by Type
9.7.2 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel
9.7.3 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration
9.7.4 Rest of LAMEA Gastrointestinal Therapeutics Market by Application
9.7.5 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 SWOT Analysis
10.2 AbbVie, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Approvals and Trials:
10.3 Takeda Pharmaceutical Company Limited
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisition and Mergers:
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.5 Salix Pharmaceuticals, Inc. (Bausch Health Companies, Inc.)
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Product Launches and Product Expansions:
10.6 Johnson & Johnson (Janssen Global Services, LLC)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental &Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 AstraZeneca PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.8 Bayer AG
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 Sun Pharmaceutical Industries Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.10. Cipla Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense

TABLE 1 LAMEA Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Branded Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Branded Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Generics Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Generics Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 LAMEA Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Online Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Online Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 18 LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 19 LAMEA Injectable Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Injectable Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Oral & Others Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Oral & Others Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 LAMEA Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 LAMEA Crohn's Disease Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Crohn's Disease Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Ulcerative Colitis Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Ulcerative Colitis Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA GERD Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA GERD Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA IBS Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA IBS Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 LAMEA Biologics/Biosimilar Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Biologics/Biosimilar Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Anti-Diarrheal Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Anti-Diarrheal Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Anti-Emetics Market by Country, 2018 - 2021, USD Million
TABLE 42 LAMEA Anti-Emetics Market by Country, 2022 - 2028, USD Million
TABLE 43 LAMEA Digestive Enzymes Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Digestive Enzymes Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Aminosalicylates Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Aminosalicylates Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Proton Pump Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Proton Pump Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 49 LAMEA Laxatives & H2 Antagonists Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Laxatives & H2 Antagonists Market by Country, 2022 - 2028, USD Million
TABLE 51 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 52 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 53 LAMEA Gastrointestinal Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 54 LAMEA Gastrointestinal Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 55 Brazil Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 56 Brazil Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 57 Brazil Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 58 Brazil Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 59 Brazil Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Brazil Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Brazil Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 62 Brazil Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 63 Brazil Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 Brazil Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 Brazil Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 66 Brazil Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 67 Argentina Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 68 Argentina Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 69 Argentina Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 70 Argentina Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 71 Argentina Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Argentina Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Argentina Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Argentina Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Argentina Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 Argentina Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 Argentina Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Argentina Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 UAE Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 80 UAE Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 81 UAE Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 82 UAE Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 83 UAE Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 UAE Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 UAE Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 86 UAE Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 87 UAE Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 88 UAE Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 89 UAE Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 90 UAE Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 91 Saudi Arabia Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 92 Saudi Arabia Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 93 Saudi Arabia Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 94 Saudi Arabia Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 95 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 96 Saudi Arabia Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 97 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 98 Saudi Arabia Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 99 Saudi Arabia Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 100 Saudi Arabia Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 101 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 102 Saudi Arabia Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 103 South Africa Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 104 South Africa Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 105 South Africa Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 106 South Africa Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 107 South Africa Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 108 South Africa Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 109 South Africa Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 110 South Africa Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 111 South Africa Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 112 South Africa Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 113 South Africa Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 114 South Africa Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 115 Nigeria Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 116 Nigeria Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 117 Nigeria Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 118 Nigeria Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 119 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 120 Nigeria Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 121 Nigeria Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 122 Nigeria Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 123 Nigeria Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 124 Nigeria Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 125 Nigeria Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 126 Nigeria Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 127 Rest of LAMEA Gastrointestinal Therapeutics Market, 2018 - 2021, USD Million
TABLE 128 Rest of LAMEA Gastrointestinal Therapeutics Market, 2022 - 2028, USD Million
TABLE 129 Rest of LAMEA Gastrointestinal Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 130 Rest of LAMEA Gastrointestinal Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 131 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 132 Rest of LAMEA Gastrointestinal Therapeutics Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 133 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 134 Rest of LAMEA Gastrointestinal Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 135 Rest of LAMEA Gastrointestinal Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 136 Rest of LAMEA Gastrointestinal Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 137 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2018 - 2021, USD Million
TABLE 138 Rest of LAMEA Gastrointestinal Therapeutics Market by Drug Class, 2022 - 2028, USD Million
TABLE 139 Key Information – Abbott Laboratories
TABLE 140 Key information – AbbVie, Inc.
TABLE 141 Key Information – Takeda Pharmaceutical Company Limited
TABLE 142 Key Information – Pfizer, Inc.
TABLE 143 key information – Salix Pharmaceuticals, Inc.
TABLE 144 Key information –Johnson & Johnson
TABLE 145 KEY INFORMATION – AstraZeneca PLC
TABLE 146 Key Information – Bayer AG
TABLE 147 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 148 Key Information – Cipla Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories
FIG 3 Recent strategies and developments: Takeda Pharmaceutical Company Limited